ORAVIG Drug Patent Profile

✉ Email this page to a colleague

When do Oravig patents expire, and when can generic versions of Oravig launch?

Oravig is a drug marketed by Galt Pharms and is included in one NDA.

The generic ingredient in ORAVIG is miconazole. There are twenty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the miconazole profile page.

Summary for ORAVIG

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	114
Patent Applications:	3,503
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for ORAVIG
What excipients (inactive ingredients) are in ORAVIG?	ORAVIG excipients list
DailyMed Link:	ORAVIG at DailyMed

Drug patent expirations by year for ORAVIG

Pharmacology for ORAVIG

Drug Class	Azole Antifungal

Anatomical Therapeutic Chemical (ATC) Classes for ORAVIG

A01AB	Antiinfectives and antiseptics for local oral treatment
A01A	STOMATOLOGICAL PREPARATIONS
A01	STOMATOLOGICAL PREPARATIONS
A	Alimentary tract and metabolism

A07AC	Imidazole derivatives
A07A	INTESTINAL ANTIINFECTIVES
A07	ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A	Alimentary tract and metabolism

D01AC	Imidazole and triazole derivatives
D01A	ANTIFUNGALS FOR TOPICAL USE
D01	ANTIFUNGALS FOR DERMATOLOGICAL USE
D	Dermatologicals

G01AF	Imidazole derivatives
G01A	ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
G01	GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
G	Genito-urinary system and sex hormones

J02AB	Imidazole derivatives
J02A	ANTIMYCOTICS FOR SYSTEMIC USE
J02	ANTIMYCOTICS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

S02AA	Antiinfectives
S02A	ANTIINFECTIVES
S02	OTOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for ORAVIG

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Galt Pharms	ORAVIG	miconazole	TABLET;BUCCAL	022404-001	Apr 16, 2010		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ORAVIG

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Galt Pharms	ORAVIG	miconazole	TABLET;BUCCAL	022404-001	Apr 16, 2010	⤷ Try a Trial	⤷ Try a Trial
Galt Pharms	ORAVIG	miconazole	TABLET;BUCCAL	022404-001	Apr 16, 2010	⤷ Try a Trial	⤷ Try a Trial
Galt Pharms	ORAVIG	miconazole	TABLET;BUCCAL	022404-001	Apr 16, 2010	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ORAVIG

See the table below for patents covering ORAVIG around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Germany	60222557		⤷ Try a Trial
Canada	2455633	SYSTEMES THERAPEUTIQUES BIOADHESIFS A LIBERATION PROLONGEE (SUSTAINED-RELEASE THERAPEUTIC BIOADHESIVE SYSTEMS)	⤷ Try a Trial
Israel	159842	SUSTAINED-RELEASE THERAPEUTIC BIOADHESIVE SYSTEMS	⤷ Try a Trial
Austria	373464		⤷ Try a Trial
Japan	4657603		⤷ Try a Trial
Denmark	1408911		⤷ Try a Trial
Japan	2010270142	LIVING BODY ADHESIVE TREATING SYSTEM WITH SUSTAINED RELEASE	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for ORAVIG

Pharmacology for ORAVIG

Anatomical Therapeutic Chemical (ATC) Classes for ORAVIG

Make Better Decisions: Try a trial or see plans & pricing